Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FORWARD PRO Study Interventional Post-market Study With the Evolut™ PRO System

NCT03417011 is registered in ClinicalTrials.gov with Medtronic Cardiovascular as lead sponsor.

NCT NCT03417011
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03417011 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FORWARD PRO Study Interventional Post-market Study With the Evolut™ PRO System
Lead sponsor
Medtronic Cardiovascular
Phase
Observational
Overall status
Completed
Start date
February 26, 2018
Completion date
February 26, 2024
Enrollment
638 (actual)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve stenosis